Accelerating cancer research discoveries for patients and the Ontario economy

OICR Researchers in the lab

OICR research

OICR is improving the prevention, detection, diagnosis and treatment of cancer. Read about the OICR programs and initiatives that are making this happen.

Read more →

CCRC - crowd pic

Canadian Cancer Research Conference

This conference brings together the Canadian cancer research community for an agenda spanning the research spectrum.

Register now →

OCREB Annual report

OCREB Annual Report

The 2016-17 Annual Report for the Ontario Cancer Research Ethics Board is now available.

Read OCREB’s Annual Report →

Kids First logo

OICR partners on Kids First DRC

The Kids First Data Resource Center (DRC) is a new cloud-based database and discovery portal that will help to better understand the link between birth defects and some childhood cancers. Read more →



FACIT helps drive oncology innovations from the lab to the marketplace where they can benefit cancer patients, researchers and meet the needs of investors in the Ontario economy.

Read more →

OICR works with other institutions

Collaborative Research Resources

OICR is making its technology infrastructure and expertise available to the Ontario cancer research community.

Read more →

Researchers in the genomics lab

Translational Research Initiatives

OICR’s new Translational Research Initiatives bring world-leading Ontario scientists together to tackle some of the most difficult to treat cancers and some of the biggest challenges in cancer today.

Read OICR’s Annual Report →

LCM in the lab


We are looking for people interested in being part of our culture of excellence that will result in Ontario being recognized internationally as a leader in cancer research.

Visit our Careers page →

Impact stories

Innovative study brings next-generation genomic sequencing to more Ontario cancer patients

More details

New prognostic test for prostate cancer now closer to clinical use

More details

Pan-Canadian research team uncovers ‘signature’ to reduce overtreatment of prostate cancer

More details